1. Home
  2. MRK
  3. MRK News

Latest Merck & Company Inc. (new) (MRK) News on February 23, 2025

2 Healthcare Stocks with Big Upside and 1 to Skip
MRK

StockStory

2 days ago

2 Healthcare Stocks with Big Upside and 1 to Skip

MRK

MT Newswires

2 days ago

Merck & Co. Insider Sold Shares Worth $714,745, According to a Recent SEC Filing

Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now
MRK

Insider Monkey

4 days ago

Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now

Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?
MRK

Insider Monkey

4 days ago

Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?

Europe Approves Merck's Cancer Drug For Two Indications
MRK

Benzinga

5 days ago

Europe Approves Merck's Cancer Drug For Two Indications

Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now
MRK

Insider Monkey

5 days ago

Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
MRK

Business Wire

5 days ago

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
MRK

Insider Monkey

6 days ago

Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?

Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
MRK

Insider Monkey

7 days ago

Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes

MRK

MT Newswires

9 days ago

Merck & Co. Insider Sold Shares Worth $512,057, According to a Recent SEC Filing

MRK

Morningstar Research

9 days ago

Analyst Report: Merck & Co., Inc.

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
MRK

Zacks

10 days ago

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck & Co., Inc. (MRK): A Bull Case Theory
MRK

Insider Monkey

10 days ago

Merck & Co., Inc. (MRK): A Bull Case Theory

US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
MRK

TechCrunch

10 days ago

US pharma giant Merck backs healthcare marketplace HD in Southeast Asia

Why Merck & Co., Inc. (MRK) is Declining
MRK

Insider Monkey

10 days ago

Why Merck & Co., Inc. (MRK) is Declining

MRK

MT Newswires

11 days ago

Guggenheim Adjusts Price Target on Merck & Co. to $115 From $122

Jim Cramer on Merck & Co., Inc. (MRK): ‘Drug Stocks Are Really Getting Hurt’
MRK

Insider Monkey

12 days ago

Jim Cramer on Merck & Co., Inc. (MRK): ‘Drug Stocks Are Really Getting Hurt’

MRK

MT Newswires

12 days ago

HSBC Adjusts Price Target on Merck to $115 From $130

Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery
MRK

CNW Group

12 days ago

Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery

MRK

MT Newswires

12 days ago

Bernstein Adjusts Price Target on Merck & Co. to $95 From $110, Keeps Market Perform Rating

In the crowded cardio space, it’s David vs. Goliath for small biotechs
MRK

Pharma Voice

12 days ago

In the crowded cardio space, it’s David vs. Goliath for small biotechs

Merck (MRK) Downgraded by TD Cowen Over Keytruda, Gardasil Concerns
MRK

Insider Monkey

12 days ago

Merck (MRK) Downgraded by TD Cowen Over Keytruda, Gardasil Concerns

MRK

Investing.com

13 days ago

TD Cowen cuts Merck stock to hold on uncertainty around Keytruda, Gardasil

MRK

Argus Research

13 days ago

Weekly Stock List

MRK

Argus Research

13 days ago

Daily – Vickers Top Buyers & Sellers for 02/10/2025

Douglas Baker Bought 1,500% More Shares In Merck
MRK

Simply Wall St.

13 days ago

Douglas Baker Bought 1,500% More Shares In Merck

MRK

MT Newswires

13 days ago

TD Cowen Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $100 From $121

Merck & Co. (MRK): ‘Forget It… It’s China,’ Jim Cramer on Vaccine Rollout Woes
MRK

Insider Monkey

13 days ago

Merck & Co. (MRK): ‘Forget It… It’s China,’ Jim Cramer on Vaccine Rollout Woes

Is Merck & Co., Inc. (MRK) the Best Dividend Stock According to Wall Street Analysts?
MRK

Insider Monkey

15 days ago

Is Merck & Co., Inc. (MRK) the Best Dividend Stock According to Wall Street Analysts?

Merck Full Year 2024 Earnings: EPS Misses Expectations
MRK

Simply Wall St.

15 days ago

Merck Full Year 2024 Earnings: EPS Misses Expectations

Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
MRK

Simply Wall St.

16 days ago

Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
MRK

Business Wire

17 days ago

Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

With uncertainty roiling Big Pharma, execs are placing lower-risk bets
MRK

Pharma Voice

17 days ago

With uncertainty roiling Big Pharma, execs are placing lower-risk bets

Is Merck & Co. (MRK) the Best Dividend Stock to Buy and Hold?
MRK

Insider Monkey

17 days ago

Is Merck & Co. (MRK) the Best Dividend Stock to Buy and Hold?

Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
MRK

Benzinga

17 days ago

Analysts Defend Merck Amid Investor Concerns Over Weak Guidance

Evaxion Biotech price target lowered to $6 from $35 at Lake Street
MRK

TipRanks

18 days ago

Evaxion Biotech price target lowered to $6 from $35 at Lake Street

Why Merck & Co. Inc. (MRK) Went Down on Tuesday
MRK

Insider Monkey

18 days ago

Why Merck & Co. Inc. (MRK) Went Down on Tuesday

Merck Is Suffering From a Classic Pharma Problem
MRK

The Wall Street Journal

18 days ago

Merck Is Suffering From a Classic Pharma Problem

Big Pharma is staying quiet on Trump's China tariffs
MRK

Quartz

18 days ago

Big Pharma is staying quiet on Trump's China tariffs

Merck & Co., Inc.'s (NYSE:MRK) latest 6.9% decline adds to one-year losses, institutional investors may consider drastic measures
MRK

Simply Wall St.

18 days ago

Merck & Co., Inc.'s (NYSE:MRK) latest 6.9% decline adds to one-year losses, institutional investors may consider drastic measures

Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ...
MRK

GuruFocus.com

18 days ago

Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ...

MRK

Thomson Reuters StreetEvents

18 days ago

Q4 2024 Merck & Co Inc Earnings Call

Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance Weigh On Shares
MRK

Investor's Business Daily

18 days ago

Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance Weigh On Shares

Merck Stock Plummets 10% As Gardasil Dynamics, 2025 Guidance Weigh On Shares
MRK

Investor's Business Daily

19 days ago

Merck Stock Plummets 10% As Gardasil Dynamics, 2025 Guidance Weigh On Shares

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China
MRK

Associated Press Finance

19 days ago

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China

Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook
MRK

Benzinga

19 days ago

Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook

Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance
MRK

Yahoo Finance

19 days ago

Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance

MRK

Investing.com

19 days ago

Merck shares tumble on Q4 earnings miss, weak 2025 guidance

CIBC introduces additional Canadian Depositary Receipts ("CDRs")
MRK

CNW Group

19 days ago

CIBC introduces additional Canadian Depositary Receipts ("CDRs")

Merck’s (NYSE:MRK) Q4 Sales Top Estimates But Stock Drops
MRK

StockStory

19 days ago

Merck’s (NYSE:MRK) Q4 Sales Top Estimates But Stock Drops

MRK

Associated Press Finance

19 days ago

Merck: Q4 Earnings Snapshot

Is Merck & Co., Inc. (MRK) the Best Cancer Stock to Buy According to Hedge Funds?
MRK

Insider Monkey

20 days ago

Is Merck & Co., Inc. (MRK) the Best Cancer Stock to Buy According to Hedge Funds?

RFK Jr.’s Financial Ties to Vaccine Lawsuits Hang Over Nomination
MRK

The Wall Street Journal

21 days ago

RFK Jr.’s Financial Ties to Vaccine Lawsuits Hang Over Nomination

Is Merck & Co. (MRK) the Best Dividend Stock on Robinhood?
MRK

Insider Monkey

21 days ago

Is Merck & Co. (MRK) the Best Dividend Stock on Robinhood?

Merck Halts Second PAH Drug Study Early on Strong Efficacy Results
MRK

Zacks

23 days ago

Merck Halts Second PAH Drug Study Early on Strong Efficacy Results

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
MRK

Yahoo Finance Video

23 days ago

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb
MRK

BioPharma Dive

23 days ago

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults
MRK

Business Wire

23 days ago

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults

Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things
MRK

Insider Monkey

24 days ago

Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
MRK

Zacks

24 days ago

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis
MRK

Business Wire

24 days ago

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis

Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100?
MRK

Insider Monkey

24 days ago

Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100?

3 Prominent US Dividend Stocks Yielding Up To 4.2%
MRK

Simply Wall St.

25 days ago

3 Prominent US Dividend Stocks Yielding Up To 4.2%

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
MRK

Investor's Business Daily

25 days ago

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings

Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
MRK

Simply Wall St.

25 days ago

Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy?
MRK

Insider Monkey

25 days ago

Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy?

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization
MRK

Business Wire

25 days ago

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization

Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?
MRK

Insider Monkey

a month ago

Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?

Merck (MRK) Earnings Expected to Grow: Should You Buy?
MRK

Zacks

a month ago

Merck (MRK) Earnings Expected to Grow: Should You Buy?

Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?
MRK

Zacks

a month ago

Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?

MRK

MT Newswires

a month ago

Citigroup Adjusts Price Target on Merck & Co. to $125 From $130, Keeps Buy Rating

Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?
MRK

Insider Monkey

a month ago

Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?

FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)
MRK

Business Wire

a month ago

FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)

Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’
MRK

Insider Monkey

a month ago

Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’

Is Merck & Co., Inc. (MRK) the Best Dow Stocks to Buy Right Now?
MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Dow Stocks to Buy Right Now?

Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now?
MRK

Insider Monkey

a month ago

Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now?

Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma
MRK

Business Wire

a month ago

Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma

Mixed results for Keytruda; AbbVie to work with Neomorph
MRK

BioPharma Dive

a month ago

Mixed results for Keytruda; AbbVie to work with Neomorph

The total return for Merck (NYSE:MRK) investors has risen faster than earnings growth over the last three years
MRK

Simply Wall St.

a month ago

The total return for Merck (NYSE:MRK) investors has risen faster than earnings growth over the last three years

Why Is Merck & Co., Inc. (MRK) Among the Best Large-Cap Value Stocks to Buy in 2025?
MRK

Insider Monkey

a month ago

Why Is Merck & Co., Inc. (MRK) Among the Best Large-Cap Value Stocks to Buy in 2025?

Here’s Why Merck & Co., Inc. (MRK) Is Among the Highest Yielding Dividend Stocks In the Dow
MRK

Insider Monkey

a month ago

Here’s Why Merck & Co., Inc. (MRK) Is Among the Highest Yielding Dividend Stocks In the Dow

Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
MRK

Investor's Business Daily

a month ago

Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines

Is Merck & Co., Inc. (MRK) the Best Stock to Invest In For Steady Dividends?
MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Stock to Invest In For Steady Dividends?

Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others
MRK

Zacks

a month ago

Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others

Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income
MRK

Benzinga

a month ago

Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income

Merck & Co., Inc. (MRK): A Bull Case Theory
MRK

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): A Bull Case Theory

Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’
MRK

Insider Monkey

a month ago

Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’

Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025?
MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025?

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
MRK

Yahoo Finance

a month ago

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
MRK

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Medicare to negotiate prices on 15 drugs, including Ozempic
MRK

Yahoo Finance Video

a month ago

Medicare to negotiate prices on 15 drugs, including Ozempic

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
MRK

Yahoo Finance

a month ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
MRK

Zacks

a month ago

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?
MRK

Zacks

a month ago

Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?

Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4
MRK

Business Wire

a month ago

Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4

Jim Cramer on Merck & Co., Inc. (MRK): ‘Down Very Badly’
MRK

Insider Monkey

a month ago

Jim Cramer on Merck & Co., Inc. (MRK): ‘Down Very Badly’

MRK

Argus Research

a month ago

Portfolio Selector for January, 2025

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Getting Pummeled’
MRK

Insider Monkey

a month ago

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Getting Pummeled’

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning
MRK

BioPharma Dive

a month ago

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

Merck Races to Launch Subcutaneous Keytruda Amid Looming Patent Expiry for IV Version
MRK

GuruFocus.com

a month ago

Merck Races to Launch Subcutaneous Keytruda Amid Looming Patent Expiry for IV Version

Share on Social Networks: